Model Brooks Nader has come forward with an admission that has sparked conversation both within the entertainment industry and among health professionals: she is still dependent on GLP-1 weight-loss drugs despite her family’s intervention. Her sisters discovered a significant amount of needles used for GLP-1 injections during an episode of her reality show, ‘Love Thy Nader,’ which led to an emotional confrontation. Nader, 28, acknowledged that she knows the drugs are not healthy for her but insists that she still relies on them as a crutch.
During a recent interview, Nader shared her perspective on the ongoing issue, stating, ‘I’m still on it. It’s a crutch for me, too.’ She admitted to feeling shame over the addiction, as many others have shared similar experiences. ‘There’s such a stigma around it,’ she said, ‘but I can relate to those who are also struggling.’ She also highlighted that her career success has been closely tied to the use of GLP-1 medications, attributing her professional growth to weight loss achieved through the treatment.
Her sisters, including Grace Ann Nader, expressed deep concern over the situation, noting the alarming amount of needles found, which they believe indicates an overprescription of the drug. ‘This is different doctors, clearly. This is different pharmacies,’ Mary Holland, one of the sisters, stated. The family members were particularly worried about the health risks associated with such extensive use, emphasizing that it is a serious issue requiring medical attention.
Brooks also revealed that there are many other models in the industry who are using GLP-1 drugs, and some agencies are even encouraging their use. This highlights the ongoing pressure within the modeling world to maintain a certain physique, which can lead individuals to take extreme measures for weight management. While Nader is aware of the potential dangers, she maintains that she does not have an eating disorder but rather an unhealthy relationship with weight and food due to the industry she is in.
Her family’s intervention has not only brought attention to the issue of GLP-1 drug use but also sparked a broader conversation about health, body image, and the pressures faced by models and celebrities in the entertainment industry. As discussions unfold, experts are calling for more awareness and support for those struggling with similar issues, emphasizing the need for healthy alternatives and proper medical guidance.